High-dose GH treatment limited to the prepubertal period in young children with idiopathic short stature does not increase adult height

Abstract

High-dose GH treatment restricted to the prepubertal period in young ISS children augments height gain during treatment, but accelerates bone maturation, resulting in a similar adult height compared with the untreated controls.